Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
UK
teenager killed by tumor not Glaxo vaccine 7:17 AM 10/1/2009
Reuters
The teenage girl who died shortly after being immunized against cervical
cancer died from a malignant chest tumor and not GlaxoSmithKline's Cervarix vaccine.
...
Sanofi
buys French biotech, seals US cancer deal 4:54 AM 10/1/2009
Reuters
Sanofi-Aventis bought biotechnology company Fovea specialized in eye
diseases and expands cancer portfolio through an exclusive worldwide drug licensing deal with Merrimack
Pharmaceuticals Inc.
...
Keep
doctors independent; ban fees from drug makers 3:51 AM 10/1/2009
Boston Globe
Money from the pharmaceutical industry can cloud a doctor's judgment
when evaluating studies and side effects on the drugs they prescribe.
...
Prescriptions
now biggest cause of fatal drug overdoses 4:18 PM 9/30/2009
USA Today
Centers for Disease Control and Prevention says prescription drugs cause
most of the more than 26,000 fatal overdoses each year. Overdose deaths from opioid painkillers more than tripled
from 1999 to 2006 with 13,800 deaths that year.
...
Orexigen, Vivus shares rise on obesity drug data 1:38 PM 9/30/2009
Forbes
Orexigen Therapeutics Inc saw positive midstage study data for its obesity
drug candidate Empatic. Investors discounted Empatic as a threat to Vivus Inc's obesity drug candidate Qnexa.
...
Caraco
Pharmaceutical and FDA on resuming manufacturing 12:12 PM 9/30/2009
Crain's Detroit
Business
Caraco Pharmaceutical Laboratories received a consent decree from the US FDA where Caraco
cannot manufacture its generic drugs in its Detroit-area plants until it receives written notification from
independent experts and the FDA that it complies with good manufacturing practices.
...
Novartis
MS Drug Points Toward 2010 Launch 10:23 AM 9/30/2009
Wall Street Journal
Novartis said a new study showed that patients taking experimental oral
multiple-sclerosis drug FTY720 (fingolimod) were more likely to go two years without a flare up.
...
Emergent
BioSolutions wins $4.9M anthrax vaccine grant 9:25 AM 9/30/2009
Bizjournals.com
Emergent BioSolutions Inc makes the only vaccine licensed by the US
FDA for the prevention of anthrax disease. The National Institute of Allergy and Infectious Diseases granted the
funds under the American Recovery and Reinvestment Act of 2009 to further develop one of its advanced anthrax
vaccine candidates.
...
Hospira
gains global biogeneric rights from Teva 7:47 AM 9/30/2009
Reuters
Hospira Inc acquired worldwide rights to a generic version of the white blood-cell
boosting drug filgrastim from Teva Pharmaceutical Industries Ltd.
...
Orexigen
says trial of 2nd obesity drug meets goal 7:42 AM 9/30/2009
Reuters
Orexigen Therapeutics Inc said a mid-stage trial of its Empatic obesity
drug met its main goal of demonstrating significant weight loss.
...
US
family doctors prescribe most mental health drugs 5:55 AM 9/30/2009
Reuters
Nearly 60 percent of US mental health drug prescriptions are written by
family doctors not psychiatrists. General practitioners prescribed the bulk of antidepressant and stimulant
prescriptions.
...
Elan
gets subpoena over Tysabri drug 12:27 PM 9/29/2009
Reuters
Elan Corp received a US Securities and Exchange Commission subpoena over its disclosure
of two cases of an often fatal brain disorder tied to use of its Tysabri multiple sclerosis drug. The subpoena
also requests records for its bapineuzumab drug intended to treat Alzheimer's disease.
...
Japan
panel backs Glaxo cervical cancer vaccine 7:23 AM 9/29/2009
Reuters
GlaxoSmithKline won support for its Cervarix cervical cancer vaccine from
an advisory panel to Japan's Health Ministry.
...
British
girl dies after cervical cancer vaccine 7:22 AM 9/29/2009
The Associated Press
A 14-year-old girl died a few hours after being the given GlaxoSmithKline's
Cervarix vaccine. No link could be made between the death and the vaccine until a post-mortem is conducted.
...
Repros
says FDA asks for more data on lead drug 6:21 AM 9/29/2009
Reuters
Repros Therapeutics Inc the US FDA asked for additional data on the
company's lead drug Proellex to resolve the clinical hold placed on it.
resolve the ...
<- Day Earlier | Today's News
|
